InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.12 per share a year ago.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Joseph Castro Nuveen LLC | 25,879 | $230,840.68 | $313,653.48 | $82,812.8 | 35.87% |
Rekah Franca Catalyst Funds Management Pty Ltd. | 18,400 | $177,290 | $229,816 | $52,526 | 29.63% |
| WM Wesley McDowell Meros Investment Management LP | 468,934 | $3.91M | $5.75M | $1.84M | 46.98% |
Taro Kuriyama Axq Capita LLP | 10,154 | $90,573.68 | $92,807.56 | $2,233.88 | 2.47% |
Hui Fai Tam Caitong International Asset Management Co. Ltd. | 2 | $17.84 | $18.28 | $0.44 | 2.47% |
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Carrie A. Lachance CEO | AMEX Exchange | 45685K102 CUSIP |
| US Country | 467 Employees | - Last Dividend | - Last Split | - IPO Date |
InfuSystem Holdings, Inc. is a prominent provider of infusion pumps and related services across the United States and Canada, functioning through its subsidiaries. Established in 2005 and based in Rochester Hills, Michigan, the company specializes in delivering comprehensive solutions for the treatment of various conditions, including cancer and pain management. InfuSystem operates through two main segments: Patient Services and Device Solutions, catering to the needs of oncology, infusion, and hospital outpatient chemotherapy clinics, among other healthcare settings.
These are supplied primarily to oncology and infusion clinics and hospital outpatient chemotherapy clinics. These pumps are essential for the treatment of various cancers, including colorectal cancer, and for pain management. They facilitate precise and controlled delivery of therapeutic agents.
InfuSystem offers both new and pre-owned pole-mounted and ambulatory infusion pumps. This range allows the company to meet the diverse needs of healthcare providers, ensuring that effective treatment options are available irrespective of the clinic's size or budget. The offer extends to other durable medical equipment, broadening the scope of solutions provided to healthcare facilities.
Alongside infusion pumps, InfuSystem provides consumable products that are essential for treatment delivery. This ensures a comprehensive solution for healthcare providers, enabling them to source both the hardware and the necessary consumables from a single provider.
With a focus on extending the life of oncology practices’ equipment, InfuSystem offers biomedical recertification, maintenance, and repair services. These services are not limited to oncology practices but are extended to various healthcare settings including hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and more. The aim is to ensure that all the equipment operates reliably and safely, minimizing downtime and enhancing patient care.
Understanding the critical role of customer support, InfuSystem offers both local and field-based assistance to address any issues or concerns that healthcare providers might have. Additionally, the company operates dedicated pump service and repair centers, ensuring that any equipment issues can be promptly and effectively resolved.